Related references
Note: Only part of the references are listed.European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines
J. Alfred Witjes et al.
EUROPEAN UROLOGY (2021)
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update
Morgan Roupret et al.
EUROPEAN UROLOGY (2021)
Update on the guideline of guidelines: non-muscle-invasive bladder cancer
Jacob Taylor et al.
BJU INTERNATIONAL (2020)
EFEMP1 as a Potential Biomarker for Diagnosis and Prognosis of Osteosarcoma
Zhuo Wang et al.
BIOMED RESEARCH INTERNATIONAL (2020)
RNA-sequencing of acute promyelocytic leukemia primary blasts reveals novel molecular biomarkers of early death events
Johann-Christoph Jann et al.
LEUKEMIA & LYMPHOMA (2020)
Overexpression of fibulin-3 in tumor tissue predicts poor survival of malignant mesothelioma patients from hand-spinning asbestos exposed area in eastern China
Zhaoqiang Jiang et al.
SCIENTIFIC REPORTS (2020)
SLC14A1 prevents oncometabolite accumulation and recruits HDAC1 to transrepress oncometabolite genes in urothelial carcinoma
Ti-Chun Chan et al.
THERANOSTICS (2020)
A genome-wide association analysis identifies 16 novel susceptibility loci for carpal tunnel syndrome
Akira Wiberg et al.
NATURE COMMUNICATIONS (2019)
Epidermal growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) suppressed the growth of hepatocellular carcinoma cells by promoting Semaphorin 3B(SEMA3B)
Jiangfeng Hu et al.
CANCER MEDICINE (2019)
Potential Benefit of Lymph Node Dissection During Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Systematic Review by the European Association of Urology Guidelines Panel on Non-muscle-invasive Bladder Cancer
Jose Luis Dominguez-Escrig et al.
EUROPEAN UROLOGY FOCUS (2019)
FBLN3 inhibits the invasion and metastasis of colorectal cancer through the AKT/mTOR pathway
H. Y. Mao et al.
NEOPLASMA (2019)
Development of a Function-Blocking Antibody Against Fibulin-3 as a Targeted Reagent for Glioblastoma
Mohan S. Nandhu et al.
CLINICAL CANCER RESEARCH (2018)
Tumor-derived fibulin-3 activates pro-invasive NF-κB signaling in glioblastoma cells and their microenvironment
M. S. Nandhu et al.
ONCOGENE (2017)
Fibulin-3 promotes osteosarcoma invasion and metastasis by inducing epithelial to mesenchymal transition and activating the Wnt/β-catenin signaling pathway
Songgang Wang et al.
SCIENTIFIC REPORTS (2017)
Transmembrane and Coiled-Coil Domain 1 Impairs the AKT Signaling Pathway in Urinary Bladder Urothelial Carcinoma: A Characterization of a Tumor Suppressor
Chien-Feng Li et al.
CLINICAL CANCER RESEARCH (2017)
MiR-338-5p suppresses proliferation, migration, invasion, and promote apoptosis of glioblastoma cells by directly targeting EFEMP1
Deqiang Lei et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
MCM10 overexpression implicates adverse prognosis in urothelial carcinoma
Wei-Ming Li et al.
ONCOTARGET (2016)
Prognostic and Prediction Tools in Bladder Cancer: A Comprehensive Review of the Literature
Luis A. Kluth et al.
EUROPEAN UROLOGY (2015)
A genome-wide association study identifies four novel susceptibility loci underlying inguinal hernia
Eric Jorgenson et al.
NATURE COMMUNICATIONS (2015)
Epigenetic regulation of EFEMP1 in prostate cancer: biological relevance and clinical potential
Mafalda Almeida et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Defining the role of common variation in the genomic and biological architecture of adult human height
Andrew R. Wood et al.
NATURE GENETICS (2014)
Fibulin-3 Promotes Glioma Growth and Resistance through a Novel Paracrine Regulation of Notch Signaling
Bin Hu et al.
CANCER RESEARCH (2012)
Combination of a Novel Gene Expression Signature with a Clinical Nomogram Improves the Prediction of Survival in High-Risk Bladder Cancer
Markus Riester et al.
CLINICAL CANCER RESEARCH (2012)
Prognostic Factors in Upper Urinary Tract Urothelial Carcinomas: A Comprehensive Review of the Current Literature
Giovanni Lughezzani et al.
EUROPEAN UROLOGY (2012)
Long-term Cancer-specific Survival in Patients with High-risk, Non-muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review
Sven van den Bosch et al.
EUROPEAN UROLOGY (2011)
Focus on molecules: Fibulin-3 (EFEMP1)
Youwen Zhang et al.
EXPERIMENTAL EYE RESEARCH (2010)
EFEMP1 binds the EGF receptor and activates MAPK and Akt pathways in pancreatic carcinoma cells
Peter Camaj et al.
BIOLOGICAL CHEMISTRY (2009)
Fibulins: Multiple roles in matrix structures and tissue functions
S. de Vega et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2009)
Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker
Ariane Sadr-Nabavi et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Frequent inactivation of RAMP2, EFEMP1 and Dutt1 in lung cancer by promoter hypermethylation
Wen Yue et al.
CLINICAL CANCER RESEARCH (2007)
Share Paper
